£129.06

Springer Bispecific Antibodies

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£129 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£141.86 £127.78 £130.85 £133.92 £137.00 £140.07 £143.14 08 March 2026 30 March 2026 21 April 2026 13 May 2026 05 June 2026

Price Distribution

Price distribution over 90 days • 3 price levels

Days at Price
Current Price
70 days · current 13 days 7 days 0 18 35 53 70 £129 £134 £142 Days at Price

Price Analysis

Most common price: £129 (70 days, 77.8%)

Price range: £129 - £142

Price levels: 3 different prices over 90 days

Description

The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy. In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Targeted Radionuclide Tumor Therapy: Biological Aspects
83% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£130.93 20 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
83% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)
83% match

Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)

Springer

£107.98 25 May 2026
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
83% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£107.63 24 May 2026
Infectious Complications in Biologic and Targeted Therapies
82% match

Infectious Complications in Biologic and Targeted Therapies

Springer

£80.64 14 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
82% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£145.54 21 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
82% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 30 May 2026
Antibodies: Volume 1: Production and Purification
81% match

Antibodies: Volume 1: Production and Purification

Springer

£124.43 01 Jun 2026
Immunotherapy for Gastrointestinal Cancer
81% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.03 05 Jun 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
81% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
81% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£74.57 31 May 2026
Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)
81% match

Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)

Springer

£77.58 03 Jun 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
81% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£111.72 29 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
80% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026
Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)
80% match

Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)

Humana

£81.58 26 May 2026
Biosensors and Their Applications
80% match

Biosensors and Their Applications

Springer

£113.09 30 May 2026
Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development: 34 (AAPS Advances in the Pharmaceutical Sciences Series, 34)
80% match

Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development: 34 (AAPS Advances in the Pharmaceutical Sciences Series, 34)

Springer

£124.31 26 May 2026
Interferons: Biological Activities and Clinical Efficacy
80% match

Interferons: Biological Activities and Clinical Efficacy

Springer

£84.99 05 Jun 2026
79% match

Biosimilars in Cancer

Academic Press

£153.99 21 May 2026
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)
79% match

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)

Springer

£75.14 05 Jun 2026
Laser Technology in Biomimetics: Basics and Applications (Biological and Medical Physics, Biomedical Engineering)
79% match

Laser Technology in Biomimetics: Basics and Applications (Biological and Medical Physics, Biomedical Engineering)

Springer

£75.25 29 May 2026
Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications
79% match

Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications

Springer

£107.98 24 May 2026
Single Cell Analysis: Contemporary Research and Clinical Applications (Series in BioEngineering)
79% match

Single Cell Analysis: Contemporary Research and Clinical Applications (Series in BioEngineering)

Springer

£121.74 05 Jun 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
79% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£107.98 01 Jun 2026